PH12016500743A1 - Treatment using bruton`s tyrosine kinase inhibitors and immunotherapy - Google Patents
Treatment using bruton`s tyrosine kinase inhibitors and immunotherapyInfo
- Publication number
- PH12016500743A1 PH12016500743A1 PH12016500743A PH12016500743A PH12016500743A1 PH 12016500743 A1 PH12016500743 A1 PH 12016500743A1 PH 12016500743 A PH12016500743 A PH 12016500743A PH 12016500743 A PH12016500743 A PH 12016500743A PH 12016500743 A1 PH12016500743 A1 PH 12016500743A1
- Authority
- PH
- Philippines
- Prior art keywords
- bruton
- tyrosine kinase
- immunotherapy
- treatment
- kinase inhibitors
- Prior art date
Links
Abstract
Combinations of Bruton's tyrosine kinase (Btk) inhibitors, e.g., l-((R)-3-(4-amino-3-(4- phenoxyphenyl)- 1 H-pyrazolo [3,4-d]pyrimidin- 1 -yl)piperidin- 1 -yl)prop-2-en- 1 -one, with immunotherapy are provided. Also provided are methods of treating cancers, and autoimmune disorders by administering combinations of Bruton's tyrosine kinase (Btk) inhibitors, e.g., 1- ((R)-3-(4-amino-3-(4-phenoxyphenyl)-lH-pyrazolo[3,4-d]pyrimidin-l-yl)piperidin-l-yl)prop-2- en-l-one, and an immune checkpoint inhibitor.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361895988P | 2013-10-25 | 2013-10-25 | |
US201361899764P | 2013-11-04 | 2013-11-04 | |
US201361911953P | 2013-12-04 | 2013-12-04 | |
US201461937392P | 2014-02-07 | 2014-02-07 | |
US201462023742P | 2014-07-11 | 2014-07-11 | |
US201462023705P | 2014-07-11 | 2014-07-11 | |
PCT/US2014/062278 WO2015061752A1 (en) | 2013-10-25 | 2014-10-24 | Treatment using bruton's tyrosine kinase inhibitors and immunotherapy |
Publications (1)
Publication Number | Publication Date |
---|---|
PH12016500743A1 true PH12016500743A1 (en) | 2016-06-20 |
Family
ID=57908617
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH12016500743A PH12016500743A1 (en) | 2013-10-25 | 2016-04-20 | Treatment using bruton`s tyrosine kinase inhibitors and immunotherapy |
Country Status (1)
Country | Link |
---|---|
PH (1) | PH12016500743A1 (en) |
-
2016
- 2016-04-20 PH PH12016500743A patent/PH12016500743A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2016005283A (en) | Treatment using bruton's tyrosine kinase inhibitors and immunotherapy. | |
PH12015502053A1 (en) | Combinations of bruton's tyrosine kinase inhibitors and cyp3a4 inhibitors | |
PH12020552065A1 (en) | Ibrutinib combination therapy | |
MX2021015408A (en) | Pharmaceutical formulations of bruton's tyrosine kinase inhibtor. | |
JOP20200222A1 (en) | Crystalline forms of a bruton’s tyrosine kinase inhibitor | |
MX2017001671A (en) | Novel formulations of a bruton's tyrosine kinase inhibitor. | |
ZA201704338B (en) | Synthesis of a bruton's tyrosine kinase inhibitor | |
PH12014502865A1 (en) | Selective pi3k delta inhibitors | |
SI3418281T1 (en) | Pyrazolo(1,5-a)pyrimidines useful as inhibitors of atr kinase for the treatment of cancer diseases | |
MX2017012411A (en) | Co-crystals of a bruton's tyrosine kinase inhibitor. | |
GEP20156333B (en) | (1,2,4)triazolo[4,3-a]quinoxaline derivatives as inhibitors of phosphodiesterases | |
MX2017012430A (en) | Solvated forms of a bruton's tyrosine kinase inhibitor. | |
PH12016500743A1 (en) | Treatment using bruton`s tyrosine kinase inhibitors and immunotherapy | |
BR112018076622A2 (en) | substituted pyrrolo [2,3-d] pyridazin-4-ones and substituted pyrazolo [3,4-d] pyridazin-4-ones as protein kinase inhibitors | |
AR098210A1 (en) | COMBINATIONS OF INHIBITORS OF THE TUTOSINA QUINASA DE BRUTON AND IMMUNOTHERAPIES | |
UY35800A (en) | COMBINATIONS OF INHIBITORS OF THE TUTOSINA QUINASA DE BRUTON AND IMMUNOTERAPIAS |